IRADIMED CORP — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-02-12

Reporting Person: Waldman Louis S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	S	4307	$25.48	Disposed	0	Direct
2020-02-12	Common Stock	M	8750	$1.29	Acquired	8750	Direct
2020-02-12	Common Stock	M	17500	$1.29	Acquired	26250	Direct
2020-02-12	Common Stock	M	8750	$1.48	Acquired	35000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Stock Option (Right to Buy)	$1.29	M	8750	Acquired		Common Stock (8750)	Direct
2020-02-12	Stock Option (Right to Buy)	$1.29	M	17500	Acquired		Common Stock (17500)	Direct
2020-02-12	Stock Option (Right to Buy)	$1.48	M	8750	Acquired		Common Stock (8750)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $25.43 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This option was granted on 11/20/2012 and is fully vested and exercisable.

F3: This option was granted on 12/13/2013 and is fully vested and exercisable.

F4: This option was granted on 12/31/2013 and is fully vested and exercisable.